Central Venous Catheters (CVCs)

Central Venous Catheters (CVCs)

Global Central Venous Catheters (CVCs) Market to Reach $1.6 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Central Venous Catheters (CVCs) estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Multi-Lumen, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$793.9 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Triple-Lumen segment is readjusted to a revised 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $388.2 Million, While China is Forecast to Grow at 7.1% CAGR

The Central Venous Catheters (CVCs) market in the U.S. is estimated at US$388.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$192 Million by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$173 Million by the year 2027.

Double-Lumen Segment to Record 4.7% CAGR

In the global Double-Lumen segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$159.1 Million in the year 2020 will reach a projected size of US$215.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.3% CAGR through the analysis period.

Select Competitors (Total 61 Featured) -

  • Amecath
  • AngioDynamics Inc.
  • B. Braun Melsungen AG
  • Bactiguard AB
  • Becton, Dickinson and Company
  • COOK MEDICAL LLC
  • Edwards Lifesciences Corporation
  • Guangdong Baihe Medical Technology Co., Ltd
  • ICU Medical, Inc.
  • Insung Medical Co. Ltd.
  • KIMAL PLC
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Vygon Ltd
  • ZOLL Medical Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Central Venous Catheters (CVCs) – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of COVID-19 Pandemic and Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Pandemic Disrupts Operations of Medical Equipment and Supplies Industry
Elective Surgeries Report Roller-Coaster Ride Amid COVID-19
COVID-19 Induced YOY Decline in Heart Surgery Volumes in the US in 2020
COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
Pandemic Affects Demand for Central Venous Catheters (CVCs)
Central Venous Catheters Remain Crucial Element of COVID-19 Patients’ Treatment
Central Venous Catheter (CVC): An Indispensable Medical Device for Healthcare Domain
Contradictions & Complications of CVCs
Types of Central Venous Catheters
Global Market Prospects & Outlook
Global Central Venous Catheters Market by Product Type (in %) for 2020E
Multi-Lumen Design Leads the CVCs Market
Antimicrobial Coated Catheters to Witness High Growth
Hospitals: The Largest End-Use Category
Developing Economies to Spearhead Long-term Growth
Competition
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Chronic Diseases Necessitate Central Venous Access, Driving Demand for CVCs
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
World Diabetes and Population Statistics (2019, 2030 & 2045)
ESRD Prevalence Worldwide: Number of Treated ESRD Patients Per Million Population in Select Countries for 2019
Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
Aging Population with Higher Susceptibility to Age-related Chronic Conditions to Drive Market Gains
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
Use of Central Venous Catheterization for Chemotherapy Administration Boosts Market Growth
Catheters Hold Vital Role in Drugs & Fluid Delivery in Cancer Treatment
Expanding Patient Population Diagnosed with Renal Diseases: Potential Growth for CVCs Market
Global Dialysis Patient Population Breakdown by Geographic Region/Country (2019 and 2024)
Catheter-Related Infections during Hemodialysis Reduce due to Hygiene Procedures
Percutaneous Translumbar Insertion for Alternate Venous Access for Dialysis of COVID-19 ARDS Patients
Surgical Procedure Volumes and Shift towards Minimal Invasive Surgeries: Significant Impact on CVCs Market
Global Volume of Surgical Procedures (in Million) by Category: 2019
Growth in the Number of Surgeries in the US (2010-2020) and 2001-2010 (in %)
Number of Surgical Procedures (per 100,000 People) in Select Countries
Central Venous Catheters: Playing Critical Role in Parenteral Nutrition
Growing Role of Central Venous Catheters in Drug Administration
Rising Use of Central Venous Catheters in ICU Settings
Growing Adoption of Antimicrobial Impregnated Catheters
Technologically Advanced CVCs Promise Better Outcomes for Interventional Procedures
3M Korea’s All-in-One PICC/CVC Securing System
Clear Correlation between CVD Risk and Central Venous Catheter Insertion Calls for Minimization of Catheter Use
Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
Challenges Facing Central Venous Catheters Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Multi-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Triple-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Double-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Single-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Non-Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Jugular Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Femoral Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 28: World Recent Past, Current & Future Analysis for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Subclavian Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 34: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 37: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: USA Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: USA 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 40: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: USA Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: USA 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 43: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: USA Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: USA 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 46: USA Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: USA Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: USA 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
TABLE 49: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Canada Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 52: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Canada Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 55: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Canada Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 58: Canada Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: Canada Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: Canada 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 61: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Japan Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 64: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Japan Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 67: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Japan Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 70: Japan Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Japan Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Japan 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 73: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: China Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: China 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 76: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: China Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: China 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 79: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: China Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: China 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 82: China Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: China Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: China 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 85: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 86: Europe Historic Review for Central Venous Catheters (CVCs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 88: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Europe Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 91: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Europe Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 94: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Europe Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 97: Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Europe Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Europe 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 100: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: France Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: France 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 103: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: France Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: France 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 106: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: France Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: France 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 109: France Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: France Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: France 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 112: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Germany Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 115: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Germany Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 118: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Germany Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 121: Germany Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Germany Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Germany 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
TABLE 124: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Italy Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 127: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Italy Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 130: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Italy Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 133: Italy Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: Italy Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Italy 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 136: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: UK Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: UK 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 139: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: UK Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: UK 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 142: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: UK Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: UK 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 145: UK Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: UK Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: UK 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
TABLE 148: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Spain Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 151: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Spain Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 154: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Spain Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 157: Spain Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Spain Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Spain 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
TABLE 160: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Russia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 163: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Russia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 166: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: Russia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 169: Russia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: Russia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: Russia 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 172: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 175: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 178: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 181: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Rest of Europe Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Rest of Europe 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 184: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 185: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 187: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 190: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 193: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 196: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 199: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Australia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 202: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Australia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 205: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Australia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 208: Australia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Australia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: Australia 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 211: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 212: India Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 213: India 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 214: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 215: India Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 216: India 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 217: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 218: India Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 219: India 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 220: India Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 221: India Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 222: India 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 223: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 224: South Korea Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 225: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 226: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 227: South Korea Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 228: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 229: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 230: South Korea Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 231: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 232: South Korea Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 233: South Korea Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 234: South Korea 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 235: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 236: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 237: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 238: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 239: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 240: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 241: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 242: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 243: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 244: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 245: Rest of Asia-Pacific Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 246: Rest of Asia-Pacific 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 247: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 248: Latin America Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 249: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 250: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 251: Latin America Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 252: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 253: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 254: Latin America Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 255: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 256: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 257: Latin America Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 258: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 259: Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 260: Latin America Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 261: Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 262: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 263: Argentina Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 264: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 265: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 266: Argentina Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 267: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 268: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 269: Argentina Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 270: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 271: Argentina Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 272: Argentina Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 273: Argentina 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
BRAZIL
TABLE 274: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 275: Brazil Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 276: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 277: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 278: Brazil Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 279: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 280: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 281: Brazil Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 282: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 283: Brazil Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 284: Brazil Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 285: Brazil 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
MEXICO
TABLE 286: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 287: Mexico Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 288: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 289: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 290: Mexico Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 291: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 292: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 293: Mexico Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 294: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 295: Mexico Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 296: Mexico Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 297: Mexico 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 298: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 299: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 300: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 301: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 302: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 303: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 304: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 305: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 306: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 307: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 308: Rest of Latin America Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 309: Rest of Latin America 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
MIDDLE EAST
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 310: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 311: Middle East Historic Review for Central Venous Catheters (CVCs) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 312: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 313: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 314: Middle East Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 315: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 316: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 317: Middle East Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 318: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 319: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 320: Middle East Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 321: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 322: Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 323: Middle East Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 324: Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
IRAN
TABLE 325: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 326: Iran Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 327: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 328: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 329: Iran Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 330: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 331: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 332: Iran Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 333: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 334: Iran Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 335: Iran Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 336: Iran 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
ISRAEL
TABLE 337: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 338: Israel Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 339: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 340: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 341: Israel Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 342: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 343: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 344: Israel Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 345: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 346: Israel Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 347: Israel Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 348: Israel 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 349: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 350: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 351: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 352: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 353: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 354: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 355: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 356: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 357: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 358: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 359: Saudi Arabia Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 360: Saudi Arabia 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 361: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 362: UAE Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 363: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 364: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 365: UAE Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 366: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 367: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 368: UAE Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 369: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 370: UAE Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 371: UAE Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 372: UAE 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 373: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 374: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 375: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 376: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 377: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 378: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 379: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 380: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 381: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 382: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 383: Rest of Middle East Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 384: Rest of Middle East 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
AFRICA
Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 385: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 386: Africa Historic Review for Central Venous Catheters (CVCs) by Design - Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 387: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by Design - Percentage Breakdown of Value Sales for Multi-Lumen, Triple-Lumen, Double-Lumen and Single-Lumen for the Years 2012, 2021 & 2027
TABLE 388: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 389: Africa Historic Review for Central Venous Catheters (CVCs) by Property - Non-Antimicrobial Coated and Antimicrobial Coated Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 390: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by Property - Percentage Breakdown of Value Sales for Non-Antimicrobial Coated and Antimicrobial Coated for the Years 2012, 2021 & 2027
TABLE 391: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 392: Africa Historic Review for Central Venous Catheters (CVCs) by Application - Jugular Vein, Femoral Vein and Subclavian Vein Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 393: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by Application - Percentage Breakdown of Value Sales for Jugular Vein, Femoral Vein and Subclavian Vein for the Years 2012, 2021 & 2027
TABLE 394: Africa Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 395: Africa Historic Review for Central Venous Catheters (CVCs) by End-Use - Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 396: Africa 15-Year Perspective for Central Venous Catheters (CVCs) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 61

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings